ArticleResearch square2025
The Polynomial Progression Subtype Inference Algorithm.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Longitudinal assessments are currently the gold standard for modeling progression of diseases, but they delay prognosis and increase burden on patients and healthcare systems. Cross-sectional inference offers a valuable alternative, enabling earlier patients' stratification and broader accessibility. Initial success in this direction has been found with the SuStaIn algorithm (Young et al. 2018) but computational and conceptual shortcomings hamper its usefulness. Here we introduce a more effective algorithm, PPSI, which is orders of magnitude faster, easier to interpret, equally or more accurate, applicable to more complex bidirectional phenomena, and can be fitted with many more variables at once. We demonstrate PPSI's utility using longitudinal prediction in Alzheimer's disease (ADNI database), clinical subtype recovery in breast cancer (TCGA-BRCA), and measurement of robustness under simulated conditions. To promote broad usability, we provide an extensive plotting suite for model exploration and diagnostics, and a graphical user interface that allows non-programmers to use the tool. While PPSI and SuStaIn are both able to derive useful subtypes from data, PPSI dramatically improves computational efficiency, enabling the inclusion of thousands of features and reducing runtimes from hours to seconds. PPSI is a performant interactive tool which makes disease progression modeling accessible to any subject matter expert.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.